NCM · Medical - Devices

BDMD (BDMD) Stock

$1.07 +1.42% NCM: BDMD Healthcare

Valuation

MetricValue
Price$1.07
Market Cap$45.16M
P/E Ratio-1.68
P/B Ratio2.18
P/S Ratio3.00
EPS (TTM)$-0.98
52-Week High$7.26
52-Week Low$0.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-87.10%
ROA-38.57%
ROCE-81.25%
Gross Margin-108.70%
Operating Margin-113.04%
Net Margin-1.21%
Debt/Equity0.62
Current Ratio1.72

Annual Financials (USD)

Metric20212022202320242025
Revenue$28.0M$35.0M$31.0M$37.0M$23.0M
Operating Profit$12.0M$14.0M$12.0M$15.0M$-26.0M
Net Profit$12.0M$13.0M$11.0M$12.0M$-27.0M
EPS$-0.02$0.02$0.41$0.49$-0.98
Op Margin43.0%38.9%37.7%41.4%-113.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$26.0M$43.0M$57.0M$78.0M$70.0M
Total Liabilities$10.0M$17.0M$21.0M$38.0M$38.0M
Cash$3.0M$2.0M$2.0M$3.0M$0
Borrowings$3.0M$7.0M$10.0M$21.0M$19.0M

Latest News

Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina PR Newswire · Jun 29, 2026 Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion PR Newswire · Jun 9, 2026 Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update PR Newswire · Apr 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$5.0M$0$-1.0M$-6.0M$-1.0M
Investing Cash Flow$-3.0M$-12.0M$-5.0M$-6.0M$0
Financing Cash Flow$4.0M$0$1.0M$-2.0M$1.0M
Net Cash Flow$2.0M$-1.0M$0$1.0M$-2.0M
Free Cash Flow$4.0M$-5.0M$-4.0M$-9.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-2.05%
Quick Ratio1.66
Interest Coverage-26.00
Return 1Y-64.73%
Return 3Y-89.54%
Return 5Y—

Ownership

Insiders Held62.51%
Institutions Held0.83%
Institutions Float Held2.20%
Institutional HolderSharesReport Date
Highbridge Capital Management, LLC.125,0002026-03-31
UBS Group AG67,8632026-03-31
Two Sigma Investments, LP46,5872026-03-31
Jane Street Group, LLC39,4162026-03-31
Geode Capital Management, LLC25,4422026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDSX $20.38 -3.09% -2.82 $165.90M 0.00%
BEAT $0.50 +0.98% -1.48 $17.10M 0.00%
CTSO $0.35 -4.32% -3.62 $22.25M 0.00%
ECORelectroCore, Inc. $6.02 -2.75% -3.42 $49.94M 0.00%
FGENFibroGen, Inc. $9.07 -1.63% 0.22 $36.69M 0.00%

About BDMD

BDMD is led by CEO Haimei Wu, employs 148 people, headquartered in CN, publicly traded since 2021.

BDMD stock trades at $1.07 with a market capitalization of $45.16M. The stock is valued at a price-to-earnings (P/E) ratio of -1.68, price-to-book of 2.18, price-to-sales of 3.00. Over the past 52 weeks the stock has ranged between $0.76 and $7.26, and currently trades 85.3% below its 52-week high.

On profitability, BDMD generates a return on equity (ROE) of -87.10%, return on capital employed of -81.25%, an operating margin of -113.04%, a net profit margin of -1.21%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides